Показано 0 из 0
Дата |
---|
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
0.725
|
0.695
|
0.725
|
0.695
|
|
|
|
|
0.64
|
0.78
|
0.665
|
0.64
|
0.67
|
0.64
|
|
|
|
|
0.65
|
0.795
|
0.69
|
0.65
|
0.69
|
0.65
|
|
|
|
|
0.675
|
0.83
|
0.71
|
0.675
|
0.715
|
0.675
|
|
|
|
|
0.67
|
0.82
|
0.705
|
0.67
|
0.705
|
0.67
|
|
|
|
|
0.685
|
0.84
|
0.715
|
0.69
|
0.72
|
0.69
|
|
|
|
|
0.67
|
0.815
|
0.705
|
0.665
|
0.705
|
0.665
|
|
|
|
|
0.665
|
0.81
|
0.71
|
0.665
|
0.71
|
0.665
|
|
|
|
|
0.665
|
0.815
|
0.70
|
0.665
|
0.70
|
0.665
|
|
|
|
|
0.64
|
0.78
|
0.695
|
0.64
|
0.695
|
0.64
|
|
|
|
|
Laekna Inc is an investment holding company mainly engaged in the discovery, development and commercialization of innovative therapies for cancer and liver disease. The Company is mainly engaged in the research and development of drug candidates for monotherapy and combination therapy, focusing on the treatment of various cancers and liver fibrosis diseases.